An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
Open accessThe DOI matches its Crossref record; 324 of the 325 references it cites were found in a registry or an index.
Abstract
This document is an international evidence-based guideline on the diagnosis and management of idiopathic pulmonary fibrosis, and is a collaborative effort of the American Thoracic Society, the European Respiratory Society, the Japanese Respiratory Society, and the Latin American Thoracic Association. It represents the current state of knowledge regarding idiopathic pulmonary fibrosis (IPF), and contains sections on definition and epidemiology, risk factors, diagnosis, natural history, staging and prognosis, treatment, and monitoring disease course. For the diagnosis and treatment sections, pragmatic GRADE evidence-based methodology was applied in a question-based format. For each diagnosis and treatment question, the committee graded the quality of the evidence available (high, moderate, low, or very low), and made a recommendation (yes or no, strong or weak). Recommendations were based on majority vote. It is emphasized that clinicians must spend adequate time with patients to discuss patients' values and preferences and decide on the appropriate course of action.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, all patients originally gathered from hospital register using ICD-10 codes were meticulously re-assessed and re-classified using the year 2011 criteria, and the cases representing some other type of ILDs were excluded [14].”
From Comparison of disease progression subgroups in idiopathic pulmonary fibrosis (2019) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“ILD still has a poor prognosis and the highest mortality rate during lung transplantation.”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [48]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interstitial lung disease (ILD) remains an important indication for lung transplantation, and the number of patients with this disease is increasing.”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [48]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Idiopathic pulmonary fibrosis (IPF), characterized histopathologically and/or radiologically with a usual interstitial pneumonia (UIP) pattern, is the most common adult form of interstitial pneumonia of unknown origin [1].”
From Lung transplantation in idiopathic pulmonary fibrosis: a systematic review of the literature (2014) · cites this paper as [1]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The median survival time for patients with IPF is 2 to 3 years from diagnosis and the 5-year survival rate ranges between 30% and 50% [1,5-7].”
From Lung transplantation in idiopathic pulmonary fibrosis: a systematic review of the literature (2014) · cites this paper as [1]
Experimental — accuracy not yet measured
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Miller, M. R., Hankinson, J., Brusasco, V., Burgos, F., Casaburi, R., Coates, A., Crapo, R., Enright, P., van der Grinten, C. P. M., Gustafsson, P., et al. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00034805 · Cited by 15,627
ATS Statement: Guidelines for the Six-Minute Walk Test
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.166.1.at1102 · Cited by 11,195
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., & Thun, M. J. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.1.43 · Cited by 7,439
Interpretative strategies for lung function tests
Pellegrino, R., Viegi, G., Brusasco, V., Crapo, R. O., Burgos, F., Casaburi, R., Coates, A., van der Grinten, C. P. M., Gustafsson, P., Hankinson, J., et al. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00035205 · Cited by 5,945
Fleischner Society: Glossary of Terms for Thoracic Imaging
Hansell, D. M., Bankier, A. A., MacMahon, H., McLoud, T. C., Müller, N. L., & Remy, J. (2008) · Radiology · doi:10.1148/radiol.2462070712 · Cited by 4,198
Self-citation(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.2.ats01 · Cited by 4,196
Standardisation of the measurement of lung volumes
Wanger, J., Clausen, J. L., Coates, A., Pedersen, O. F., Brusasco, V., Burgos, F., Casaburi, R., Crapo, R., Enright, P., van der Grinten, C. P. M., et al. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00035005 · Cited by 2,768
Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment: International Consensus Statement
(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.2.ats3-00 · Cited by 2,628
Standardisation of the single-breath determination of carbon monoxide uptake in the lung
MacIntyre, N., Crapo, R. O., Viegi, G., Johnson, D. C., van der Grinten, C. P. M., Brusasco, V., Burgos, F., Casaburi, R., Coates, A., Enright, P., et al. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00034905 · Cited by 2,255
NOCTURNAL OXYGEN THERAPY TRIAL GROUP* (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-3-391 · Cited by 2,218
Research works printed but not linked: 9
- Cochrane Handbook for Systematic Reviews of Interventions 5.0.2. Oxford: The Cochrane Collaboration, 2009. [online] 2009. [accessed 20 June 2010]; Available from: http://www.cochrane.org/resources/handbook/.
- Nadrous HF, Ryu JH, Douglas WW, Decker PA, Olson EJ. Impact of angiotensin-converting enzyme inhibitors and statins on survival in idiopathic pulmonary fibrosis. Chest 2004;126:438–446. [DOI] [PubMed] [Google Scholar]
- 2005, J Gastrointest Surg, 1053
- Marshall RP, Puddicombe A, Cookson WO, Laurent GJ. Adult familial cryptogenic fibrosing alveolitis in the UK. Thorax 2000;55:143–146. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gross TJ, Hunninghake GW. Idiopathic pulmonary fibrosis. N Engl J Med 2001;345:517–525. [DOI] [PubMed] [Google Scholar]
- Kondo A, Saiki S. Acute exacerbation in idiopathic interstitial pneumonia (IIP). In: Harasawa M, Fukuchi Y, Morinari H, editors. Interstitial pneumonia of unknown etiology. Tokyo: University of Tokyo Press; 1989. pp. 33–42.
- Flaherty KR, Colby TV, Toews GB, Travis WD, Flint A, Gay SE, Strawderman RL III, Jain A, Lynch JP III, Martinez FJ. Differential presence of fibroblastic foci in UIP patients with or without conntective tissue disease. Am J Respir Crit Care Med 2001;163:A983. [Google Scholar]
- Molina-Molina M, Badia JR, Marin-Arguedas A, Xaubet A, Santos MJ, Nicolas JM, Ferrer M, Torres A. Outcomes and clinical characteristics of patients with pulmonary fibrosis and respiratory failure admitted to an intensive care unit: a study of 20 cases. Med Clin (Barc) 2003;121:63–67. [DOI] [PubMed] [Google Scholar]
- Pitsiou G, Ioannis Trigonis I, Tsiata E, Kontou P, Manolakoglou N, Stanopoulos I, Mavrofridis E, Argyropoulou P. Outcome of patients with pulmonary fibrosis admitted to the ICU for acute respiratory failure. Eur Respir J Suppl 2006;28:E650. [Google Scholar]
Cited by
Items 601–700 of 1,060
Cough in idiopathic pulmonary fibrosis
van Manen, M. J. G., Birring, S. S., Vancheri, C., Cottin, V., Renzoni, E. A., Russell, A.-M., & Wijsenbeek, M. S. (2016) · European Respiratory Review · doi:10.1183/16000617.0090-2015 · Cited by 114
Raghu, G. (2011) · European Respiratory Journal · doi:10.1183/09031936.00017711 · Cited by 114
Self-citationMarigliano, B., Soriano, A., Margiotta, D. P. E., Vadacca, M., & Afeltra, A. (2013) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.05.001 · Cited by 114
Ash, S. Y., Harmouche, R., Lassala, D., Villalba, J. A., Ostridge, K., Gunville, R., Come, C. E., Onieva, J. O., Ross, J. C., Hunninghake, G. M., et al. (2017) · Respiratory Research · doi:10.1186/s12931-017-0527-8 · Cited by 114
Satō, T., Kondo, H., Watanabe, A., Nakajima, J., Niwa, H., Horio, H., Okami, J., Okumura, N., Sugio, K., Teramukai, S., et al. (2014) · General Thoracic and Cardiovascular Surgery · doi:10.1007/s11748-014-0487-6 · Cited by 114
Self-citationAcute exacerbation of idiopathic pulmonary fibrosis-a review of current and novel pharmacotherapies.
Juarez, M. M., Chan, A. L., Norris, A., Morrissey, B. M., & Albertson, T. E. (2015) · PubMed Central · doi:10.3978/j.issn.2072-1439.2015.01.17 · Cited by 114
Todd, N., Scheraga, Galvin, Iacono, Britt, Luzina, Burke, & Atamas (2013) · Journal of Inflammation Research · doi:10.2147/jir.s40673 · Cited by 113
Exercise Limitation in IPF Patients: A Randomized Trial of Pulmonary Rehabilitation
Jackson, R. M., Gómez-Marín, O., Ramos, C. F., Sol, C., Cohen, M. I., GAUNAURD, I. A., Cahalin, L. P., & Cardenas, D. D. (2014) · Lung · doi:10.1007/s00408-014-9566-9 · Cited by 113
The lived experience with idiopathic pulmonary fibrosis: a qualitative study
Overgaard, D., Kaldan, G., Marsaa, K., Nielsen, T. L., Shaker, S. B., & Egerod, I. (2016) · European Respiratory Journal · doi:10.1183/13993003.01566-2015 · Cited by 113
Idiopathic Pulmonary Fibrosis: From Epithelial Injury to Biomarkers - Insights from the Bench Side
Kolb, Borensztajn, K., Crestani, B., & Kolb, M. (2013) · Respiration · doi:10.1159/000357598 · Cited by 113
Pathogenesis, current treatments and future directions for idiopathic pulmonary fibrosis
Loomis-King, H. A., Flaherty, K. R., & Moore, B. B. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.03.015 · Cited by 113
Self-citationSwigris, J. J., Han, M. K., Vij, R., Noth, I., Eisenstein, E. L., Anstrom, K. J., Brown, K. K., & Fairclough, D. L. (2012) · Respiratory Medicine · doi:10.1016/j.rmed.2012.06.018 · Cited by 113
Self-citationLung cancer risk among patients with combined pulmonary fibrosis and emphysema
Kwak, N., Park, C. M., Lee, J., Park, Y. S., Lee, S., Yim, J., Yoo, C., Kim, Y. W., Han, S., & Lee, C. (2014) · Respiratory Medicine · doi:10.1016/j.rmed.2013.11.013 · Cited by 113
Wnt Coreceptor Lrp5 Is a Driver of Idiopathic Pulmonary Fibrosis
Lam, A. P., Herazo-Maya, J. D., Sennello, J. A., Flozak, A. S., Russell, S., Mutlu, G. M., Budinger, G. R. S., DasGupta, R., Varga, J., Kaminski, N., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201401-0079oc · Cited by 112
Ganganah, O., Guo, S. L., Chiniah, M., & Li, Y. S. (2016) · Respirology · doi:10.1111/resp.12770 · Cited by 112
[18F]FDG PET/CT predicts progression-free survival in patients with idiopathic pulmonary fibrosis
Justet, A., Laurent-Bellue, A., Thabut, G., Dieudonné, A., Debray, M., Borie, R., Aubier, M., Lebtahi, R., & Crestani, B. (2017) · Respiratory Research · doi:10.1186/s12931-017-0556-3 · Cited by 112
Fibulin-1c regulates transforming growth factor–β activation in pulmonary tissue fibrosis
Liu, G., Cooley, M. A., Jarnicki, A., Borghuis, T., Nair, P. M., Tjin, G., Hsu, A., Haw, T. J., Fricker, M., Harrison, C. L., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.124529 · Cited by 111
Russell, A.-M., Ripamonti, E., & Vancheri, C. (2016) · BMC Pulmonary Medicine · doi:10.1186/s12890-016-0171-y · Cited by 111
Molecular Magnetic Resonance Imaging of Pulmonary Fibrosis in Mice
Caravan, P., Yang, Y., Zachariah, R., Schmitt, A., Mino-Kenudson, M., Chen, H. H., Sosnovik, D. E., Dai, G., Fuchs, B. C., & Lanuti, M. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0039oc · Cited by 110
S2K-Leitlinie zur Diagnostik und Therapie der idiopathischen Lungenfibrose
Behr, J., Günther, A., Ammenwerth, W., Bittmann, I., Bonnet, R. B., Buhl, R., Eickelberg, O., Ewert, R., Gläser, S., Gottlieb, J., et al. (2013) · Pneumologie · doi:10.1055/s-0032-1326009 · Cited by 110
Self-citationHagmeyer, L., Theegarten, D., Wohlschläger, J., Treml, M., Matthes, S., Priegnitz, C., & Randerath, W. J. (2015) · The Clinical Respiratory Journal · doi:10.1111/crj.12261 · Cited by 110
Kato, M., Sasaki, S., Nakamura, T., Kurokawa, K., Yamada, T., Ochi, Y., Ihara, H., Takahashi, F., & Takahashi, K. (2019) · Scientific Reports · doi:10.1038/s41598-019-48593-4 · Cited by 110
Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition
Kyung, S. Y., Kim, D. Y., Yoon, J. Y., Son, E. S., Kim, Y. J., Park, J. W., & Jeong, S. H. (2018) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-018-0204-7 · Cited by 110
Self-citationEffect of Emphysema Extent on Serial Lung Function in Patients with Idiopathic Pulmonary Fibrosis
Cottin, V., Hansell, D. M., Sverzellati, N., Weycker, D., Antoniou, K. M., Atwood, M., Oster, G., Kirchgaessler, K.-U., Collard, H. R., & Wells, A. U. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201612-2492oc · Cited by 110
Self-citationSingle-Cell Profiling Reveals Immune Aberrations in Progressive Idiopathic Pulmonary Fibrosis
Unterman, A., Zhao, A., Neumark, N., Schupp, J. C., Ahangari, F., Cosme, C., Sharma, P., Flint, J., Stein, Y., Ryu, C., et al. (2024) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202306-0979oc · Cited by 110
Outcomes After Hospitalization in Idiopathic Pulmonary Fibrosis
Brown, A. W., Fischer, C. P., Shlobin, O. A., Buhr, R. G., Ahmad, S., Weir, N. A., & Nathan, S. D. (2014) · CHEST Journal · doi:10.1378/chest.13-2424 · Cited by 110
The disturbed redox-balance in pulmonary fibrosis is modulated by the plant flavonoid quercetin
Veith, C., Drent, M., Bast, A., van Schooten, F., & Boots, A. W. (2017) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2017.10.001 · Cited by 110
Biomarkers in idiopathic pulmonary fibrosis
Zhang, Y., & Kaminski, N. (2012) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e328356d03c · Cited by 109
Phase 2 clinical trial of PBI-4050 in patients with idiopathic pulmonary fibrosis
Khalil, N., Manganas, H., Ryerson, C. J., Shapera, S., Cantin, A. M., Hernandez, P., Turcotte, E. E., Parker, J. M., Moran, J. E., Albert, G. R., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.00663-2018 · Cited by 109
Clinical outcomes of lung transplant recipients with telomerase mutations
Tokman, S., Singer, J. P., Devine, M. S., Westall, G. P., Aubert, J.-D., Tamm, M., Snell, G. I., Lee, J. S., Goldberg, H. J., Kukreja, J., et al. (2015) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2015.05.002 · Cited by 109
Ravaglia, C., Wells, A. U., Tomassetti, S., Dubini, A., Cavazza, A., Piciucchi, S., Sverzellati, N., Gurioli, C., Gurioli, C., Costabel, U., et al. (2017) · Respiration · doi:10.1159/000456671 · Cited by 109
Self-citationYao, M., Zhang, W., Ma, W., Liu, Q., Xing, L., & Zhao, G.-F. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0255-x · Cited by 109
Maher, T. M., Molina-Molina, M., Russell, A.-M., Bonella, F., Jouneau, S., Ripamonti, E., Axmann, J., & Vancheri, C. (2017) · BMC Pulmonary Medicine · doi:10.1186/s12890-017-0468-5 · Cited by 108
Quantitative Proteomics of Bronchoalveolar Lavage Fluid in Idiopathic Pulmonary Fibrosis
Foster, M. W., Morrison, L. D., Todd, J. L., Snyder, L. D., Thompson, J. W., Soderblom, E. J., Plonk, K., Weinhold, K. J., Townsend, R., Minnich, A., et al. (2015) · Journal of Proteome Research · doi:10.1021/pr501149m · Cited by 108
Bing, P., Zhou, W., & Tan, S. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.865065 · Cited by 108
Respiratory and lower limb muscle function in interstitial lung disease
Panagiotou, M., Polychronopoulos, V., & Strange, C. (2016) · Chronic Respiratory Disease · doi:10.1177/1479972315626014 · Cited by 108
Functional Impact of a Spectrum of Interstitial Lung Abnormalities in Rheumatoid Arthritis
Doyle, T. J., Dellaripa, P. F., Batra, K. L., Frits, M. L., Iannaccone, C. K., Hatabu, H., Nishino, M., Weinblatt, M. E., Ascherman, D. P., Washko, G. R., et al. (2013) · CHEST Journal · doi:10.1378/chest.13-1394 · Cited by 108
Hernández‐González, F., Lucena, C. M., Ramírez, J., Sánchez, M., Jimenez, M. J., Xaubet, A., Sellarés, J., & Agustí, C. (2014) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2014.09.009 · Cited by 108
GDF15 is an epithelial-derived biomarker of idiopathic pulmonary fibrosis
Zhang, Y., Jiang, M., Nouraie, M., Roth, M. G., Tabib, T., Winters, S., Chen, X., Sembrat, J., Chu, Y., Cardenes, N., et al. (2019) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00062.2019 · Cited by 107
Lung Collagens Perpetuate Pulmonary Fibrosis via CD204 and M2 Macrophage Activation
Stahl, M., Schupp, J., Jäger, B., Schmid, M., Zissel, G., Müller-Quernheim, J., & Prasse, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081382 · Cited by 107
Park, Y., Ahn, C., & Kim, T.-H. (2021) · Scientific Reports · doi:10.1038/s41598-021-81591-z · Cited by 107
Recombinant human serum amyloid P in healthy volunteers and patients with pulmonary fibrosis
Dillingh, M. R., van den Blink, B., Moerland, M., van Dongen, M. G. J., Levi, M. M., KleinJan, A., Wijsenbeek, M. S., Lupher, M., Harper, D. M., Getsy, J. A., et al. (2013) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2013.01.008 · Cited by 107
Smith, M. L., Dalurzo, M. C. L., Panse, P. M., Parish, J. M., & Leslie, K. O. (2013) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2013-201442 · Cited by 107
Kaushik, S. S., Freeman, M. S., Yoon, S. W., Liljeroth, M. G., Stiles, J. V., Roos, J. E., Michael Foster, W. S., Rackley, C. R., McAdams, H. P., & Driehuys, B. (2014) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00326.2014 · Cited by 107
The diagnosis of idiopathic pulmonary fibrosis: current and future approaches
Martinez, F. J., Chisholm, A., Collard, H. R., Flaherty, K. R., Myers, J., Raghu, G., Walsh, S. L. F., White, E. S., & Richeldi, L. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(16)30325-3 · Cited by 107
Self-citationDuerr, J., Leitz, D. H. W., Szczygiel, M., Dvornikov, D., Fraumann, S. G., Kreutz, C., Zadora, P. K., Seyhan Agircan, A., Konietzke, P., Engelmann, T. A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15743-6 · Cited by 107
Patients with IPF and lung cancer: diagnosis and management
Τzouvelekis, Α., Spagnolo, P., Bonella, F., Vancheri, C., Tzilas, V., Crestani, B., Kreuter, M., & Bouros, D. E. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30478-2 · Cited by 107
Self-citationCriteria for the diagnosis of idiopathic pleuroparenchymal fibroelastosis: A proposal
Watanabe, K., Ishii, H., Kiyomi, F., Terasaki, Y., Hebisawa, A., Kawabata, Y., Johkoh, T., Sakai, F., Kondoh, Y., Inoue, Y., et al. (2019) · Respiratory Investigation · doi:10.1016/j.resinv.2019.02.007 · Cited by 107
Self-citationConte, E., Gili, E., Fruciano, M., Korfei, M., Fagone, E., Iemmolo, M., Furno, D. L., Giuffrida, R., Crimi, N., Günther, A., et al. (2013) · Laboratory Investigation · doi:10.1038/labinvest.2013.6 · Cited by 106
Safety and efficacy of pirfenidone in idiopathic pulmonary fibrosis in clinical practice
Okuda, R., Hagiwara, E., Baba, T., Kitamura, H., Kato, T., & Ogura, T. (2013) · Respiratory Medicine · doi:10.1016/j.rmed.2013.06.011 · Cited by 106
Ley, B., Bradford, W. Z., Vittinghoff, E., Weycker, D., du Bois, R. M., & Collard, H. R. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201508-1546oc · Cited by 106
Self-citationOda, K., Ishimoto, H., Yatera, K., Naito, K., Ogoshi, T., Yamasaki, K., Imanaga, T., Tsuda, T., Nakao, H., Kawanami, T., et al. (2014) · Respiratory Research · doi:10.1186/1465-9921-15-10 · Cited by 106
Maher, T. M., Stowasser, S., Nishioka, Y., White, E. S., Cottin, V., Noth, I., Selman, M., Rohr, K. B., Michael, A., Ittrich, C., et al. (2019) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(19)30255-3 · Cited by 106
Self-citationCombined inhibition of TGFβ and PDGF signaling attenuates radiation-induced pulmonary fibrosis
Dadrich, M., Nicolay, N. H., Flechsig, P., Bickelhaupt, S., Hoeltgen, L., Roeder, F., Hauser, K., Tietz, A., Jenne, J., Perez, R. L., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1123366 · Cited by 106
Baseline characteristics and comorbidities in the CAnadian REgistry for Pulmonary Fibrosis
Fisher, J. H., Kolb, M. R. J., Algamdi, M., Morisset, J., Johannson, K. A., Shapera, S., Wilcox, P., To, T. M., Sadatsafavi, M., Manganas, H., et al. (2019) · BMC Pulmonary Medicine · doi:10.1186/s12890-019-0986-4 · Cited by 106
Exosomal Long Non-Coding RNAs in Lung Diseases
Poulet, C., Njock, M., Moermans, C., Louis, E. J., Louis, R. E., Malaise, M., & Guiot, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103580 · Cited by 106
Are mast cells instrumental for fibrotic diseases?
Overed-Sayer, C., Rapley, L., Mustelin, T., & Clarke, D. L. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00174 · Cited by 105
Iwata, T., Yoshida, S., Fujiwara, T., Wada, H., Nakajima, T., Suzuki, H., & Yoshino, I. (2016) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2016.05.094 · Cited by 105
Salisbury, M. L., Hewlett, J. C., Ding, G., Markin, C. R., Douglas, K., Mason, W., Guttentag, A., Phillips, J. A., Cogan, J. D., Reiss, S., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201909-1834oc · Cited by 105
Self-citationReactive oxygen species as signaling molecules in the development of lung fibrosis
Gonzalez-Gonzalez, F. J., Chandel, N. S., Jain, M., & Budinger, G. R. S. (2017) · Translational Research · doi:10.1016/j.trsl.2017.09.005 · Cited by 105
Maher, T. M., Kreuter, M., Lederer, D. J., Brown, K. K., Wuyts, W. A., Verbruggen, N., Stutvoet, S., Fieuw, A. M., Ford, P., Abi‐Saab, W., et al. (2019) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2019-000422 · Cited by 105
Self-citationGriff, S., Schönfeld, N., Ammenwerth, W., Blum, T.-G., Grah, C., Bauer, T. T., Grüning, W., Mairinger, T., & Wurps, H. (2014) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-14-171 · Cited by 105
Hetzel, J., Eberhardt, R., Petermann, C., Gesierich, W., Darwiche, K., Hagmeyer, L., Muche, R., Kreuter, M., Lewis, R., Ehab, A., et al. (2019) · Respiratory Research · doi:10.1186/s12931-019-1091-1 · Cited by 105
Interstitial lung disease diagnosis and prognosis using an AI system integrating longitudinal data
Mei, X., Liu, Z., Singh, A. P., Lange, M., Boddu, P., Gong, J. Q. X., Lee, J., DeMarco, C., Cao, C., Platt, S., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37720-5 · Cited by 105
A Phase II Clinical Trial of Low-Dose Inhaled Carbon Monoxide in Idiopathic Pulmonary Fibrosis
Rosas, I. O., Goldberg, H. J., Collard, H. R., El‐Chemaly, S., Flaherty, K. R., Hunninghake, G. M., Lasky, J. A., Lederer, D. J., Machado, R. F., Martínez, F. J., et al. (2017) · CHEST Journal · doi:10.1016/j.chest.2017.09.052 · Cited by 105
Self-citationInterstitial Lung Diseases in Developing Countries
Rivera‐Ortega, P., & Molina‐Molina, M. (2019) · Annals of Global Health · doi:10.5334/aogh.2414 · Cited by 105
Li, L., Liu, R., Zhang, Y., Zhou, J., Li, Y., Xu, Y., Gao, S., & Zheng, Y. (2019) · Clinical Rheumatology · doi:10.1007/s10067-019-04846-1 · Cited by 105
Perceptions, experiences and needs of patients with idiopathic pulmonary fibrosis
Duck, A., Spencer, L. G., Bailey, S. F., Leonard, C. T., Ormes, J., & Caress, A. (2014) · Journal of Advanced Nursing · doi:10.1111/jan.12587 · Cited by 105
Tortora, M., Gemini, L., D’Iglio, I., Ugga, L., Spadarella, G., & Cuocolo, R. (2022) · Journal of Imaging · doi:10.3390/jimaging8040112 · Cited by 105
Pamrevlumab for Idiopathic Pulmonary Fibrosis: The ZEPHYRUS-1 Randomized Clinical Trial
Raghu, G., Richeldi, L., Pérez, E. R. F., Salvo, M. C. D., Silva, R. S., Song, J. W., Ogura, T., Xu, Z., Belloli, E. A., Zhang, X., et al. (2024) · JAMA · doi:10.1001/jama.2024.8693 · Cited by 104
Self-citationRicheldi, L., Cottin, V., Flaherty, K. R., Kolb, M., Inoue, Y., Raghu, G., Taniguchi, H., Hansell, D. M., Nicholson, A. G., Le Maulf, F., et al. (2014) · Respiratory Medicine · doi:10.1016/j.rmed.2014.04.011 · Cited by 104
Self-citationon behalf of the IPF-PRO Registry investigators, Todd, J. L., Vinisko, R., Liu, Y., Neely, M. L., Overton, R., Flaherty, K. R., Noth, I., Newby, L. K., Lasky, J. A., et al. (2020) · BMC Pulmonary Medicine · doi:10.1186/s12890-020-1103-4 · Cited by 104
Self-citationRaghu, G., van den Blink, B., Hamblin, M. J., Brown, A. W., Golden, J. A., Ho, L. A., Wijsenbeek, M. S., Vašáková, M., Pesci, A., Antin-Ozerkis, D. E., et al. (2019) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(19)30172-9 · Cited by 104
Self-citationTzilas, V., Bouros, E., Barbayianni, I., Karampitsakos, T., Kourtidou, S., Ntassiou, M., Ninou, I., Aidinis, V., Bouros, D. E., & Τzouvelekis, Α. (2019) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2019.01.003 · Cited by 104
Self-citationHanda, T., Tanizawa, K., Oguma, T., Uozumi, R., Watanabe, K., Tanabe, N., Niwamoto, T., Shima, H., Mori, R., Nobashi, T. W., et al. (2022) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202101-044oc · Cited by 104
Suzuki, Y., Yoshimura, K., Enomoto, Y., Yasui, H., Hozumi, H., Karayama, M., Furuhashi, K., Enomoto, N., Fujisawa, T., Nakamura, Y., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-32478-z · Cited by 104
Oishi, K., Mimura‐Kimura, Y., Miyasho, T., Aoe, K., Ogata, Y., Katayama, H., Murata, Y., Ueoka, H., Matsumoto, T., & Mimura, Y. (2012) · Cytokine · doi:10.1016/j.cyto.2012.08.032 · Cited by 104
Hodnett, P. A., & Naidich, D. P. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201208-1544ci · Cited by 104
Sun, B., Shi, Y., Yang, L., Jiang, J., Liang, S., Duan, J., & Sun, Z. (2019) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2019.121566 · Cited by 104
Burkhardt, A. M., Tai, K. P., Flores-Guiterrez, J. P., Vilches‐Cisneros, N., Kamdar, K., Barbosa-Quintana, O., Valle‐Rios, R., Hevezi, P. A., Zúñiga, J., Selman, M., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102903 · Cited by 104
Self-citationKatzenstein, A.-L. A. (2013) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2012-201338 · Cited by 104
Guérin, C., Bayle, F., Leray, V., Debord, S., Stoian, A. C., Yonis, H., Roudaut, J.-B., Bourdin, G., Devouassoux‐Shisheboran, M., Bucher, E., et al. (2014) · Intensive Care Medicine · doi:10.1007/s00134-014-3583-2 · Cited by 104
Predicting Life Expectancy for Pirfenidone in Idiopathic Pulmonary Fibrosis
Fisher, M., Nathan, S. D., Hill, C., Marshall, J., Dejonckheere, F., Thuresson, P.-O., & Maher, T. M. (2017) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2017.23.3-b.s17 · Cited by 103
miR-92a regulates TGF-β1-induced WISP1 expression in pulmonary fibrosis
Berschneider, B., Ellwanger, D. C., Baarsma, H. A., Thiel, C., Shimbori, C., White, E. S., Kolb, M. R. J., Neth, P., & Königshoff, M. (2014) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2014.06.011 · Cited by 103
Rush, B. N. M., Wiskar, K., Berger, L., & Griesdale, D. E. G. (2015) · Respiratory Medicine · doi:10.1016/j.rmed.2015.12.005 · Cited by 103
Richeldi, L., Kreuter, M., Selman, M., Crestani, B., Kirsten, A.-M., Wuyts, W. A., Xu, Z., Bernois, K., Stowasser, S., Quaresma, M., et al. (2018) · Thorax · doi:10.1136/thoraxjnl-2016-209701 · Cited by 103
Self-citationInterstitial Lung Abnormality: Recognition and Perspectives
Hatabu, H., Hunninghake, G. M., & Lynch, D. A. (2018) · Radiology · doi:10.1148/radiol.2018181684 · Cited by 103
Self-citationThe circadian clock protein REVERBα inhibits pulmonary fibrosis development
Cunningham, P. S., Meijer, P., Nazgiewicz, A., Anderson, S. G., Borthwick, L. A., Bagnall, J., Kitchen, G. B., Lodyga, M., Begley, N., Venkateswaran, R., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1912109117 · Cited by 103
GLUT1-dependent glycolysis regulates exacerbation of fibrosis via AIM2 inflammasome activation
Cho, S. J., Moon, J., Nikahira, K., Yun, H. S., Harris, R. A., Hong, K. S., Huang, H., Choi, A. M. K., & Stout-Delgado, H. W. (2019) · Thorax · doi:10.1136/thoraxjnl-2019-213571 · Cited by 103
Pulmonary Rehabilitation in Patients with Idiopathic Pulmonary Fibrosis - A Review
Kenn, K., Gloeckl, R., & Behr, J. (2013) · Respiration · doi:10.1159/000354112 · Cited by 103
Self-citationJohn, A. E., Luckett, J., Tatler, A. L., Awais, R. O., Desai, A., Habgood, A., Ludbrook, S. B., Blanchard, A. D., Perkins, A. C., Jenkins, G. R., et al. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.120592 · Cited by 102
Mast Cells and Fibroblasts Work in Concert to Aggravate Pulmonary Fibrosis
Wygrecka, M., Dahal, B. K., Kosanovic, D., Petersen, F., Taborski, B., von Gerlach, S., Didiasova, M., Zakrzewicz, D., Preissner, K. T., Schermuly, R. T., et al. (2013) · The American Journal of Pathology · doi:10.1016/j.ajpath.2013.02.013 · Cited by 102
Treatment and outcome of lung cancer in idiopathic interstitial pneumonias.
Kreuter, M., Ehlers-Tenenbaum, S., Schaaf, M., Oltmanns, U., Palmowski, K., Hoffmann, H., Schnabel, P. A., Heußel, C. P., Puderbach, M., Herth, F. J. F., et al. (2015) · Sarcoidosis vasculitis and diffuse lung diseases · Cited by 102
Transbronchial biopsy is useful in predicting UIP pattern
Tomassetti, S., Cavazza, A., Colby, T. V., Ryu, J. H., Nanni, O., Scarpi, E., Tantalocco, P., Buccioli, M., Dubini, A., Piciucchi, S., et al. (2012) · Respiratory Research · doi:10.1186/1465-9921-13-96 · Cited by 102
Self-citationChoi, M., Ban, T., & Rhim, T. (2014) · Molecules and Cells · doi:10.14348/molcells.2014.2317 · Cited by 102
Enomoto, Y., Takemura, T., Hagiwara, E., Iwasawa, T., Fukuda, Y., Yanagawa, N., Sakai, F., Baba, T., Nagaoka, S., & Ogura, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073774 · Cited by 102
Treatment of idiopathic pulmonary fibrosis: a network meta-analysis
Rochwerg, B., Neupane, B., Zhang, Y., Garcia, C. C., Raghu, G., Richeldi, L., Brozek, J., Beyene, J., & Schünemann, H. (2016) · BMC Medicine · doi:10.1186/s12916-016-0558-x · Cited by 101
Self-citationRole of matrix metalloprotease-2 and MMP-9 in experimental lung fibrosis in mice
Bormann, T., Maus, R., Stolper, J., Tarrés, M. T., Brandenberger, C., Wedekind, D., Jonigk, D. D., Welte, T., Gauldie, J., Kolb, M. R. J., et al. (2022) · Respiratory Research · doi:10.1186/s12931-022-02105-7 · Cited by 101
Pirfenidone: In Idiopathic Pulmonary Fibrosis
Carter, N. J. (2011) · Drugs · doi:10.2165/11207710-000000000-00000 · Cited by 101
Marshall, D. C., Salciccioli, J. D., Shea, B. S., & Akuthota, P. (2018) · European Respiratory Journal · doi:10.1183/13993003.01603-2017 · Cited by 101
Metadata
- Authors
- Raghu, G., Collard, H. R., Egan, J. J., Martinez, F. J., Behr, J., Brown, K. K., Colby, T. V., Cordier, J.-F., Flaherty, K. R., Lasky, J. A., Lynch, D. A., Ryu, J. H., Swigris, J. J., Wells, A. U., Ancochea, J., Bouros, D., Carvalho, C., Costabel, U., Ebina, M., Hansell, D. M., Johkoh, T., Kim, D. S., King, T. E., Kondoh, Y., Myers, J., Müller, N. L., Nicholson, A. G., Richeldi, L., Selman, M., Dudden, R. F., Griss, B. S., Protzko, S. L., & Schünemann, H. J.
- Affiliations
- University of Washington (US)
- University of California, San Francisco (US)
- Mater Misericordiae University Hospital (IE)
- Ludwig-Maximilians-Universität München (DE)
- Mayo Clinic (US)
- University of Michigan (US)
- Tulane University (US)
- University of Colorado Boulder (US)
- National Jewish Health (US)
- Royal Brompton Hospital (GB)
- Hospital Universitario de La Princesa (ES)
- University Hospital of Alexandroupolis (GR)
- Universidade de São Paulo (BR)
- Tohoku University (JP)
- Royal Brompton & Harefield NHS Foundation Trust (GB)
- The University of Osaka (JP)
- University of Ulsan (KR)
- University of Modena and Reggio Emilia (IT)
- Instituto Nacional de Enfermedades Respiratorias (MX)
- ORCID
- Raghu, Ganesh
- Collard, Harold R.
- Colby, Thomas V.
- Lasky, Joseph A.
- Lynch, David A.
- Ryu, Jay H.
- Swigris, Jeffrey J.
- Wells, Athol U.
- Ancochea, Julio
- Bouros, Demosthenes
- Carvalho, Carlos
- Costabel, Ulrich
- Johkoh, Takeshi
- King, Talmadge E.
- Kondoh, Yasuhiro
- Myers, Jeffrey
- Nicholson, Andrew G.
- Richeldi, Luca
- Selman, Moisés
- Schünemann, Holger J.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-03
- Volume
- 183
- Issue
- 6
- Pages
- 788-824
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- PMC
- PMC5450933
- OpenAlex
- W2167383172
- Cited by
- 7,186
- References
- 325
- Citations by year
- 2026: 187 · 2025: 307 · 2024: 436 · 2023: 432 · 2022: 522 · 2021: 640 · 2020: 607 · 2019: 596 · 2018: 607 · 2017: 605 · 2016: 569 · 2015: 531 · 2014: 426 · 2013: 370 · 2012: 256
- FWCI
- 304.18
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion, public-domain)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by)
- Funders
- National Heart, Lung, and Blood Institute (K23HL092227)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Keywords
- idiopathic pulmonary fibrosis, diagnosis, management, natural history (disease), staging, prognosis, risk factors, treatment, disease surveillance, GRADE
- MeSH terms
- Europe, Humans, International Cooperation, Japan, Latin America, Societies, Medical, United States, Evidence-Based Medicine, Idiopathic Pulmonary Fibrosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.